The Tuberculosis Treatment Pipeline: A Breakthrough Year for the Treatment of XDR-TB
July 2017 By Marcus Low Editor's note: This version has been modified from the original print version on August 7, 2017 to reflect recent updates and clarify the status of access to delamanid. INTRODUCTION Arguably, the most critical questions in…